# N-Gene Research Laboratories

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/n-gene-research-laboratories

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.ngene.us
- Total disclosed funding: $3M
- Latest round: Series B (Apr 7, 2006)
- Investors on record: 1

## About

N-Gene Research Laboratories, Inc. is focused on delivering innovative digital solutions, particularly in web hosting and related services aimed at enhancing online presence for businesses.Founded in 1997 and headquartered in New York, US, N-Gene Research Laboratories, Inc. specializes in digital services. The company has undergone key developments, including its latest funding round, a Series B that raised USD 3 million from Hiventures in April 2006, bringing the total amount raised to USD 3 million. The current CEO is Gabor Kalman.N-Gene Research Laboratories offers a variety of digital solutions, primarily in managed web hosting, domain registration, and cloud services. Their offerings are tailored for small to medium-sized businesses across multiple industries, providing essential tools for a robust online presence. The company serves clients in North America, Europe, and Asia, ensuring reliable website operations and efficient data management.The company generates revenue through subscription-based models for web hosting and domain registration services, with clients engaging in monthly or annual contracts. The revenue structure also includes tiered pricing plans based on service levels, which may offer enhanced features. Additionally, N-Gene benefits from partnerships with web developers and agencies that resell their services, alongside supplementary offerings such as premium support and additional software tools.N-Gene Research Laboratories plans to utilize its recently raised USD 3 million from the Series B financing to expand its product offerings and enhance existing services. The company is focused on launching new solutions that cater specifically to the evolving needs of their clients by the end of 2023. Furthermore, N-Gene aims to penetrate new markets, with targeted expansion into specific regions in Europe and Asia over the next two years.

## Funding rounds

- Series B, Apr 7, 2006, $3M — Hiventures

## Investors

- Hiventures (https://capitalatlas.ai/funds/hiventures) — Series B